|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61P 17/14 | (2018.01) |
| C07C 255/60 | (2006.01) | ||
| A61K 31/277 | (2006.01) | ||
| A61P 1/18 | (2018.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| C07C 255/60 | (2013.01) | ||
| A61P 19/00 | (2018.01) | ||
| A61P 17/10 | (2018.01) | ||
| A61P 5/24 | (2018.01) | ||
| A61P 21/00 | (2018.01) | ||
| A61P 13/00 | (2018.01) | ||
| A61P 13/08 | (2018.01) | ||
| A61P 17/08 | (2018.01) | ||
| A61P 21/02 | (2018.01) | ||
| A61P 5/28 | (2018.01) | ||
| A61P 1/16 | (2018.01) | ||
| A61P 11/00 | (2018.01) | ||
| A61P 35/02 | (2018.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61P 15/00 | (2018.01) | ||
| A61P 1/04 | (2018.01) | ||
| A61P 17/00 | (2018.01) | ||
| A61K 31/277 | (2013.01) | ||
| A61P 13/12 | (2018.01) | ||
| A61P 25/00 | (2018.01) | ||
| C07B2200/07 | (2013.01) |
| (11) | Number of the document | 3285757 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16783846.5 |
| Date of filing the European patent application | 2016-04-21 | |
| (97) | Date of publication of the European application | 2018-02-28 |
| (45) | Date of publication and mention of the grant of the patent | 2021-09-22 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/028623 |
| Date | 2016-04-21 |
| (87) | Number | WO 2016/172330 |
| Date | 2016-10-27 |
| (30) | Number | Date | Country code |
| 201562150768 P | 2015-04-21 | US | |
| 201562220094 P | 2015-09-17 | US |
| (72) |
NARAYANAN, Ramesh , US
MILLER, Duane D. , US
PONNUSAMY, Thamarai , KR
HWANG, Dong-Jin , US
DUKE, Charles B. , US
COSS, Christopher C. , US
JONES, Amanda , US
DALTON, James T. , US
|
| (73) |
Oncternal Therapeutics, Inc. ,
12230 El Camino Real, Suite 300, San Diego, CA 92130,
US
University of Tennessee Research Foundation , 211 Conference Center Building 600 Henley Street, Knoxville, TN 37996, US |
| (54) | SELECTIVE ANDROGEN RECEPTOR DEGRADER (SARD) LIGANDS AND METHODS OF USE THEREOF |
| SELECTIVE ANDROGEN RECEPTOR DEGRADER (SARD) LIGANDS AND METHODS OF USE THEREOF |